A rare case of extramedullary plasmacytoma (EMP) arising from the lacrimal gland of a 33-year-old woman is presented. The left lacrimal gland tumor was suspected, and tumorectomy was performed. Histopathological examination with immunostaining revealed it to be positive for IgG and κ chains, demonstrating monoclonality. However, no abnormality was observed on serum protein electrophoresis, immunofixation, or skeletal survey and bone marrow aspiration, and the tumor was diagnosed as EMP. Postoperative radiation was given to the left orbit by a linear at a dose of 40 Gy. One year and 10 months have passed since the operation, and the patient’s general condition is good, without local recurrence of tumor, lymph node metastasis, or remote metastasis. The EMP should be considered in the differential diagnosis of lacrimal gland tumor.
European Journal of Plastic Surgery – Springer Journals
Published: Dec 1, 2005
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera